Oshiro Tomoko, Fukutomi Yumiko, Takayanagi Megumi, Kusaba Koji, Nagasawa Zenzo, Aoki Yosuke, Nagayama Ariaki
Department of Microbiology and Immunology, Fukuoka University, Fukuoka, Japan.
Jpn J Antibiot. 2003 Dec;56(6):681-90.
We determined the antibacterial activities of oral Cephems against isolated from the patients with the respiratory infections, the urinary tract infections, and infections in the obstetrics field of an adult and a child, during the period from 2002 to 2003; Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, Branhamella catarrhalis, Klebsiella pneumoniae and Escherichia coli of 40 strains of each, and Peptostreptococcus spp. 22 strains. S. pneumoniae and H. influenzae strains that resistant is regarded were collected mainly, penicillin-intermediate S. pneumoniae (PISP), penicillin-resistant S. pneumoniae (PRSP) and beta-lactamase negative ampicillin-resistant H. influenzae (BLNAR) strains. The MICs of Cephems except cefaclor (CCL) were < or = 0.03 microgram/mL against all strains of S. pyogenes. The MICs of cefteram (CFTM) and cefditoren (CDTR) were < or = 0.0125 microgram/mL activity against 7 strains penicillin-susceptible S. pneumoniae (PSSP). However the MIC90s of cefditoren (CDTR) was 1 microgram/mL, cefteram (CFTM), and cefcapene (CFPN) were 2 micrograms/mL against PISP and PRSP, were higher than those of other drugs, but showed slightly higher than PSSP. The MIC90s of Cephems. were 0.5-4 micrograms/mL against strains of E. coli. The MIC90s of CFTM was 0.5 microgram/mL, and CDTR, CFPN were 1 microgram/mL against E. coli were higher than those of other drugs. The four strains of E. coli however were highly-resistant which MIC90s of CCL were more than 32 micrograms/mL were obtains. Furthermore it is necessary to pay much attention to the trend of resistant such as E. coli of Cephems. Although all strains showed resistant to AMPC, MIC90 of Cephems were 0.25-1 microgram/mL, good activities against K. pneumoniae. Against beta-lactamase negative ampicillin-susceptible H. influenzae (BLNAS) 23 strains the MIC90s of CCL and other Cephems were 64 micrograms/mL and 0.25-8 micrograms/mL. The MIC90s of CDTR and CFTM were < or = 1 microgram/mL of BLNAR (15 strains). However there of CFDN and CPDX were 8 micrograms/mL and CCL were > or = 16 micrograms/mL. Two strains which were produced beta-lactamase were highly--ABPC resistant. Although B. catarrhalis all strains were produced beta-lactamase and Cephems except for CCL showed better susceptibility than AMPC. The MIC90s of Cephems were 0.25-2 micrograms/mL against Peptostreptococcus spp.
我们测定了口服头孢菌素对2002年至2003年期间从成人和儿童的呼吸道感染、尿路感染及产科感染患者中分离出的细菌的抗菌活性;化脓性链球菌、肺炎链球菌、流感嗜血杆菌、卡他莫拉菌、肺炎克雷伯菌和大肠埃希菌各40株,消化链球菌属22株。主要收集了被视为耐药的肺炎链球菌和流感嗜血杆菌菌株,即青霉素中介肺炎链球菌(PISP)、青霉素耐药肺炎链球菌(PRSP)和β-内酰胺酶阴性氨苄西林耐药流感嗜血杆菌(BLNAR)菌株。除头孢克洛(CCL)外,头孢菌素对所有化脓性链球菌菌株的MIC均≤0.03微克/毫升。头孢特仑(CFTM)和头孢妥仑(CDTR)对7株青霉素敏感肺炎链球菌(PSSP)的活性MIC≤0.0125微克/毫升。然而,头孢妥仑(CDTR)对PISP和PRSP的MIC90为1微克/毫升,头孢特仑(CFTM)和头孢卡品(CFPN)为2微克/毫升,高于其他药物,但略高于PSSP。头孢菌素对大肠埃希菌菌株的MIC90为0.5 - 4微克/毫升。头孢特仑(CFTM)对大肠埃希菌的MIC90为0.5微克/毫升,头孢妥仑(CDTR)和头孢卡品(CFPN)为1微克/毫升,高于其他药物。然而,有4株大肠埃希菌高度耐药,其CCL的MIC90超过32微克/毫升。此外,有必要密切关注头孢菌素对大肠埃希菌等耐药趋势。尽管所有菌株对氨曲南均耐药,但头孢菌素对肺炎克雷伯菌的MIC90为0.25 - 1微克/毫升,活性良好。对23株β-内酰胺酶阴性氨苄西林敏感流感嗜血杆菌(BLNAS),CCL和其他头孢菌素的MIC90分别为64微克/毫升和0.25 - 8微克/毫升。头孢妥仑(CDTR)和头孢特仑(CFTM)对BLNAR(15株)的MIC90≤1微克/毫升。然而,头孢地尼(CFDN)和头孢丙烯(CPDX)的为8微克/毫升而CCL的≥16微克/毫升。两株产β-内酰胺酶的菌株对氨苄西林高度耐药。尽管卡他莫拉菌所有菌株均产β-内酰胺酶,除CCL外的头孢菌素比氨曲南显示出更好的敏感性。头孢菌素对消化链球菌属的MIC90为0.25 - 2微克/毫升。